RPRX
Royalty Pharma plc
Stock
$57.16−0.47 (−0.82%)Close Oct 2, 2026
- EBITDA, 2025
- $1.6B
- YoY, 2025
- +21.0%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $1.6B | +21.0% |
| 2024 | $1.3B | −13.4% |
| 2023 | $1.5B | — |
Royalty Pharma plc
$57.16−0.47 (−0.82%)Close Oct 2, 2026
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $1.6B | +21.0% |
| 2024 | $1.3B | −13.4% |
| 2023 | $1.5B | — |